{
    "doi": "https://doi.org/10.1182/blood-2020-133039",
    "start_url": "https://ashpublications.org/blood/search-results?sort=Date+-+Oldest+First&f_ArticleTypeDisplayName=Meeting+Report&fl_SiteID=1000001&page=4563",
    "start_url_page_num": 4563,
    "is_scraped": "1",
    "article_title": "Bioengineering Strategies to Phenotypically Define Minimal Residual Disease ",
    "article_date": "November 5, 2020",
    "session_type": ".Getting the Most from Minimal Residual Disease",
    "topics": null,
    "author_names": [
        "Scott R. Manalis, PhD"
    ],
    "author_affiliations": [
        [
            "Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA"
        ]
    ],
    "first_author_latitude": "42.3623099",
    "first_author_longitude": "-71.0893571"
}